Proposed Rule on Interoperability Standards and Prior Authorization for Medicare and Medicaid Programs
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This proposed rule aims to enhance the electronic exchange of healthcare data, focusing on prior authorization processes across Medicare Advantage, Medicaid, and related programs. It will require impacted payers to implement electronic prior authorization for drugs, expand API requirements, and adopt specific interoperability standards by October 2027. The rule affects insurers and healthcare providers, aiming to streamline processes and reduce administrative burdens.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Requires electronic prior authorization for drugs in Medicare and Medicaid by October 2027.
- Mandates expanded API reporting and interoperability standards.
- Introduces penalties for non-compliance in data reporting.
Obligations
What this law requires
Implement electronic prior authorization for drugs for Medicare Advantage organizations, state Medicaid FFS programs, state CHIP FFS programs, Medicaid managed care plans, CHIP managed care entities, and QHP issuers on FFEs by October 2027
Extend existing interoperability requirements for prior authorization of non-drug items and services to include prior authorizations for drugs
Report API endpoints and related information for Patient Access, Provider Directory, Provider Access, Payer-to-Payer, and Prior Authorization APIs to CMS
Collect and report API usage metrics to CMS for Patient Access, Provider Directory, Provider Access, Payer-to-Payer, and Prior Authorization APIs
Implement required HL7 FHIR implementation guides that are currently recommended for health information exchange